resveratrol has been researched along with Dengue in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alagarasu, K; Cherian, S; Kakade, MB; Kasabe, B; Parashar, D; Patil, P; Punekar, M | 1 |
| Jiang, Y; Liu, C; Liu, X; Wang, T; Wu, H; Wu, P; Yan, Q; Zhan, S; Zheng, W | 1 |
| Hitakarun, A; Paemanee, A; Roytrakul, S; Smith, DR | 1 |
| AbuBakar, S; Anderson, R; Chang, CP; Chen, CL; Cheng, YL; Ho, TS; Lin, YS; Wan, SW; Wu, YW; Zainal, N | 1 |
4 other study(ies) available for resveratrol and Dengue
| Article | Year |
|---|---|
A Transcriptomics-Based Bioinformatics Approach for Identification and In Vitro Screening of FDA-Approved Drugs for Repurposing against Dengue Virus-2.
Topics: Antiviral Agents; Computational Biology; Dengue; Dengue Virus; Doxorubicin; Drug Repositioning; Enalaprilat; Humans; Methyltransferases; Molecular Docking Simulation; Peptide Hydrolases; Resveratrol; RNA-Dependent RNA Polymerase; Transcriptome; Viral Nonstructural Proteins | 2022 |
Identification of COVID-19 and Dengue Host Factor Interaction Networks Based on Integrative Bioinformatics Analyses.
Topics: Antiviral Agents; Chemokine CCL2; Coinfection; Computational Biology; COVID-19; COVID-19 Drug Treatment; Dengue; Dengue Virus; Dexamethasone; Gene Expression Regulation; Genistein; Humans; Intercellular Adhesion Molecule-1; Lung; Protein Interaction Maps; Resveratrol; SARS-CoV-2; Signal Transduction | 2021 |
Screening of melatonin, α-tocopherol, folic acid, acetyl-L-carnitine and resveratrol for anti-dengue 2 virus activity.
Topics: Acetylcarnitine; alpha-Tocopherol; Antiviral Agents; Dengue; Dengue Virus; Folic Acid; HEK293 Cells; Hep G2 Cells; Humans; Melatonin; Resveratrol; Stilbenes | 2018 |
Resveratrol treatment reveals a novel role for HMGB1 in regulation of the type 1 interferon response in dengue virus infection.
Topics: Antiviral Agents; Cell Line, Tumor; Cell Nucleus; Dengue; Dengue Virus; HMGB1 Protein; Humans; Interferon Type I; Interferon-beta; Myxovirus Resistance Proteins; Promoter Regions, Genetic; Protein Binding; Resveratrol; RNA Interference; RNA, Small Interfering; Sirtuin 1; Stilbenes; Virus Replication | 2017 |